Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, ...

Columnist Oluwatosin Adesoye explains why preventing malaria infections is particularly important for those with sickle cell ...

Sickle cell disease doesn’t discriminate, but it does disproportionately affect those with the least access to healthcare ...

New gene therapy improves the life of 18-year-old with Sickle Cell Disease which affects 5,000 New Jersey residents living ...

Sanofi announced today that the U.S. FDA has granted orphan drug designation to rilzabrutinib for the treatment of sickle ...

Adolescents and young adults with sickle cell disease may face challenges in accessing physical therapy, a study reports.

The Pediatric Emergency Medicine and Pediatric Hematology/Oncology divisions at the Medical University of South Carolina ...